mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |